• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Otoraplin (OTOR)

ACP18905

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP18905 Target NameOTOR
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Expression Range18-128Protein LengthFull Length of Mature Protein
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9NRC9
Background Information
  • Uniprot Id

    Q9NRC9

  • Target Species

    Human

  • Target Name

    OTOR

  • Target Full Name

    Otoraplin

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    MIA/OTOR family

  • Target Tissue Specificity

    Highly expressed in cochlea.

  • Target Synonyms

    FDP; Fibrocyte derived protein; Fibrocyte-derived protein; Melanoma inhibitory activity like protein; Melanoma inhibitory activity-like protein; MGC126737; MGC126739; MIAL; MIAL1; OTOR; OTOR_HUMAN; Otoraplin; OTTHUMP00000030323

Inquire Recombinant Human Otoraplin (OTOR) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification